Testosterone does not affect lower urinary tract symptoms while improving markers of prostatitis in men with benign prostatic hyperplasia: a randomized clinical trial
ConclusionsTwenty-four weeks of TTh in TD men with BPH and MetS improves ultrasound, molecular and histological proxies of prostate inflammation. This does not result in symptom improvement.
Source: Journal of Endocrinological Investigation - Category: Endocrinology Source Type: research
More News: AndroGel | Benign Prostatic Hyperplasia | Clinical Trials | Endocrinology | Genetics | Low Testosterone | Metabolic Syndrome | Ultrasound